Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Purpose. To explore the safety and efficacy of gemcitabine and docetaxel (GEMDOC) in previously treated patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods. Patients with advanced SCCHN previously pretreated with one or two lines of pallia...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kafri, Zyad, Heilbrun, Lance K., Sukari, Ammar, Yoo, George, Jacobs, John, Lin, Ho-Sheng, Mulrenan, Heather, Smith, Daryn, Kucuk, Omer
Format: Artigo
Idioma:Inglês
Publicat: International Scholarly Research Network 2012
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359684/
https://ncbi.nlm.nih.gov/pubmed/22655205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/159568
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars